-
Merck Makes a $2.8 Billion Bet on an Experimental New Cancer Drug
Post on 11/6/20
-
Teladoc Health: A Quantitative Valuation
Post on 11/6/20
-
Is Teladoc Health a Buy on the Pullback?
Post on 11/6/20
-
Caladrius Biosciences Provides Corporate Update
Post on 11/5/20
-
CorMedix Provides Business Update
Post on 11/5/20
-
Celldex Provides Corporate Update
Post on 11/5/20
-
BD Announces Fiscal Fourth Quarter And Full Year 2020 Results
Post on 11/5/20
-
Cigna Reports Third Quarter 2020 Performance
Post on 11/5/20
-
Esteemed Panel of National Experts to Lead Peer-to-Peer Healthcare Technology Security Symposium
Post on 11/5/20
-
Bellerophon Provides Clinical Program Update and Reports Third Quarter 2020 Financial Results
Post on 11/5/20
-
Prestige Consumer Healthcare Reports Fiscal 2021 Second Quarter Results
Post on 11/5/20
-
22nd Century Group Reports Financial Results and Business Highlights for the Third Quarter 2020
Post on 11/5/20
-
Athenex Reports Third Quarter Ended September 30, 2020 Financial Results and Provides Corporate Update
Post on 11/5/20
-
Axsome Therapeutics Reports Third Quarter 2020 Financial Results and Provides Business Update
Post on 11/5/20
-
Outlook Therapeutics Secures $10 Million
Post on 11/5/20
-
Arvinas Reports Third Quarter 2020 Financial Results and Provides Corporate Update
Post on 11/5/20
-
VYNE Therapeutics Reports Third Quarter 2020 Financial Results and Provides Business Update
Post on 11/5/20
-
Antares Pharma Reports Strong Third Quarter 2020 Financial and Operating Results
Post on 11/5/20
-
Amicus Therapeutics Announces Third Quarter 2020 Financial Results and Corporate Updates
Post on 11/5/20
-
Here's What's Behind Bristol Myers Squibb's Huge Acquisitions
Post on 11/5/20
-
Rocket Pharmaceuticals Reports Third Quarter 2020 Financial Results
Post on 11/4/20
-
Conversion Labs Close $15 Million Private Placement
Post on 11/4/20
-
Protara Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Post on 11/4/20
-
Teladoc and Livongo Demolished Expectations. So Why Are Their Stocks Down?
Post on 11/4/20
-
Tabula Rasa HealthCare Reports Third Quarter 2020 Results
Post on 11/4/20
New York
